Company History
Company History
April
2000
- Joint venture with Bexcom Co.,Ltd., Heye Investment Co.,Ltd., Chiayi Investment Co.,Ltd., established Bestchain Online Business Co., Ltd., and entered into the medical health e-commerce field.
November
1999
- Built internal resources to integrate, JDE information management system.
July
1998
- The Company was approved as a public company by Securities and Futures Commission, Ministry of Finance to improve management performance.
June
1998
- The Company entered globalization era, joint venture with RTS Worldwide Holding Inc, a subsidiary company of Baxter International, and planed to establish “Jiate Excesior Co., Ltd.” to expand and manage hemodialysis related business.
October
1997
- The IT department completed Internet structure and integrated the Internet and the Intranet. IT department began to replace out-of-date components and servers to solve the millennium bug crisis.
January
1997
- Completed intranet structure, and the management of operation entered into e-commerce.
May
1996
- Established Kaohsiung office to expand the sales channels, and built a maintenance team in southern Taiwan.
February
1992
- Established Taichung office to expand the sales channels, and built a maintenance team in central Taiwan
March
1989
- In responding to business expansion, Enfield Medical Supply Ltd. was changed to Enfield Medical Co., Ltd.
March
1988
- Enfield Medical Supply Ltd. was established and elected Hui-Tung Fu as the first chairman. The Company engaged in the sale of hemodialysis medical devices, wound and ostomy medical products.
December
2010
- The subsidiary, Dynamic Medical Technologies Inc., terminated the trading of its shares on TPEx emerging stock market and listed on Taipei Exchange on December 29, 2010.
June
2009
- The Company's name was formally changed from “Enfield Medical Co., Ltd.” to “Excelsior Medical Co., Ltd.”
November
2008
- Signed a share exchange agreement with Jiuyu Investment Co., Ltd. and issued new shares due to acquisition of 51% shares of Arich Enterprise Co., Ltd. held by Jiuyu Investment Co., Ltd.
September
2008
- Invested Asia Best Healthcare Co., Ltd. to expand the long-term care business in Greater China Area.
December
2007
- The Company’s stock terminated the trading of its shares on Taipei Exchange and listed on the Taiwan Stock Exchange on December 31, 2007.
May
2007
- The subsidiary, Dynamic Medical Technologies Inc., invested in Great China Technology Development Limited into the international aesthetic medical field.
January
2007
- The Company sold 51% shares of its subsidiary Jiate Excesior Co., Ltd. to Fresenius Medical Care Hong Kong Co., Ltd. joint venture to expand hemodialysis business.
January
2006
- Upgraded internal resource to integrate ERP system for effectiveness.
- To streamline the affiliates, Bestchain Healthtaiwan Co., Ltd. and Chiayi Applied Technology Co., Ltd. merged, and the former is the surviving company.
March
2005
- Purchased all shares of Jiate Excesior Co., Ltd. invested by RTS Worldwide Holding Inc., which is the subsidiary of Baxter International, and obtained channels of the entire hemodialysis of that company.
April
2004
- Invested in Dynamic Medical Technologies Inc., and entered into the aesthetic medical field.
October
2003
- Puchased Zhonghe Office to establish the Group headquarter.
March
2003
- Invested in Excelsior Healthcare Co., Limited, an overseas holding company in the British Virgin Islands, engaged in the investment and operation of the medical industry in Asia and overseas. The company established EG Healthcare, Inc. to develop medical-related industries in the Philippines.
June
2001
- Public trading could commence on June 8, 2001 pursuant to authorization from Taipei Exchange.
February
2001
- The company was approved as “biotechnology stock” by Taipei Exchange, stock code is 4104 which officially qualified to list stock.
December
2020
- The Company acquired import certificate of NIKKISO’s new model DBB-EXA ES hemodialysis machine approved by Ministry of Health and Welfare. The new model DBB-EXA ES hemodialysis machine added new functions, including online hemodialysis powder infusion and data output communication interface. In addition to meeting current medical requirements, also enhance the product’s sales strength by adding various functions.
May
2020
- The Company acquired normal saline permit license and outsourced manufacturing to ASTAR CHEMICAL & PHAR CO., LTD..
April
2020
- Arich Enterprise Co., Ltd. issued 30 million shares for capital injection. Shares were issued at NT$15 per share, and NT$450,000,000 was raised. After the capital injection, share capital was NT$745,743,550.
January
2020
- Issued 13 million shares for capital injection. Shares were issued at NT$45 per share, and NT$585,000,000 was raised. After the capital injection, share capital was NT$1,411,489,700.
October
2019
- In October 2019, SinoExcelsior Investment Inc. adjusted management strategies and disposed its entire shares in Beijing Sinoexcelsior Investment Management Co., Ltd. and Shanghai Wanli Medical Cosmetology Clinic Co., Ltd., a 100% owned subsidiary of Beijing Sinoexcelsior.
August
2019
- The Company acquired 51% of the shares of Shinkong Excelsior Medical Asset Management Co., Ltd., increasing the Company's shareholding ratio from 49% to 100%, and the name of the subsidiary was changed to Excelsior Asset Management Co., Ltd.
June
2019
- Elections for the 12th board of directors (including independent directors) in the shareholders’ meeting.
November
2018
- 1.The Subsidiary, SinoExcelsior Investment Inc., adjusted its operation strategy to reduce capital and change its company name and business content. It was approved to change its registered Chinese name. 2.The Subsidiary, Excelsior Healthcare Co., Limited established Excelsior Investment (Malatsia) Co., Ltd. to develop the Southeast Asia market. 3.Acquired 70% shares in RENAL LABORATORIES SDN. BHD. and MEDI CHEM SYSTEMS SDN. BHD. through the subsidiary, Excelsior Investment (Malatsia) Co., Ltd., By investing in dialysate manufacturer in Malaysia, the Company looks to expand into the hemodialysis market and enter into dialysis-related products manufacturing in Southeast Asia.
December
2017
- The Company acquired 100% of SinoExcelsior Investment Inc.(Its original name is Yujia Medical Service Co., Ltd.) from Sinopharm Group Co.,Ltd. through Excelsior Medical (HK) Co., Limited upon the completion of this transation in order to expand to madical industries in China region.
July
2017
- The Company merged with its subsidiary Animation Medical Technologies Ltd. to integrate group resource. The Company was the surviving company, and to further develop the field of agency and maintenance of water treatment equipment.
June
2016
- Established Audit Committee to strengthen the corporate governance system.
October
2015
- The Company established Shinkong Excelsior Asset Management Co., Ltd. as a joint venture. The parties conbined their respective advantageous resources to develop real estate business in medical-related industries.
October
2014
- The Company and the subsidiary Dynamic Medical Technologies Inc. invested Caregen Co., Ltd. shares in October 2014 to develop proprietary, patented peptide technology for hair growth, hair care treatment and to promote products from DR.CYJ brand.
October
2013
- The subsidiary, Arich Enterprise Co., Ltd., terminated the trading of its shares on TPEx emerging stock market and listed on Taipei Exchange on October 31, 2013.
November
2012
- 1.The Company originally invested in Asia Best Healthcare Co., Ltd. through Excelsior Healthcare Co., Limited. Due to expansion of business in Greater China Area, the investment framework was restructured and shares of Asia Best Healthcare Co., Ltd. were transferred from Excelsior Healthcare Co., Limited to Excelsior Medical (HK) Co., Limited.
- 2.Excelsior Medical (HK) Co., Limited carried out capital injection, and the shares were purchased by Excelsior Healthcare Co., Limited. After the capital injection of Excelsior Medical (HK) Co., Limited, the Company and Excelsior Healthcare Co., Limited hold its shares respectively.
December
2011
- Established Remuneration Committee to implement corporate governance and integrity codes.
May
2011
- Yujia Medical Service Co., Ltd. was established as a joint venture through Excelsior Medical (HK) Co., Limited to develop medical industry in China region.
February
2011
- Established the subsidiary, Excelsior Medical (HK) Co., Limited, to invest medical industry in China region.
April
2022
- Acquired 49% shares in NephroCare Limited and Cardinal Medical Services Ltd. through the subsidiary, Excelsior Medical (HK) Co., Limited. The joint venture between the two parties further expanded the operation of hemodialysis-related business.
